"Studying healthcare disparities in HD based on clinical data may be a better way of evaluating the extent of disparities in HD care and outcomes. We also need to rely on qualitative data, including ...
Beta-blocker use is associated with a 34% reduction of onset in premanifest Huntington disease (preHD) and slower progression in early motor-manifest Huntington disease (mmHD), new research shows. In ...
The presentation highlights additional positive topline results from SAD/MAD study and preclinical data of SKY-0515, a novel small molecule designed to reduce both HTT and PMS1 proteins, two key ...
"Based on our findings, we simulated a hypothetical interventional study for patients with JOHD and found that use of the JOHD Scale as the primary outcome measure resulted in reduction in the total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback